1Y Annualised Return
▼-22.95%
3Y Annualised Return
▼-10.82%
5Y Annualised Return
▲14.86%
10Y Annualised Return
▲5.52%
Sandu Pharmaceuticals Stock Performance
|
|
|
Sandu Pharmaceuticals Company background
Founded in: 1985
Managing director: Umesh B Sandu
Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU.SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.94, to partfinance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations. This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards. Ayurvedic products have a very good market in India and abroad due to their minimal side effects.The company commenced commercial production of Ayurvedic Medicines Formulations, at the Goa plant in 199697. Thereafter, it commenced production of manufacturing Unit II in Goa from May, 2002.
Sandu Pharmaceuticals Financial Highlights
Sandu Pharmaceuticals reported a Q2 FY2025–2026 revenue of ₹14.07 crore, down -0.5% YoY, with net profit increased 6.2% to ₹0.33 crore. For the full year FY2025–2026, revenue reached ₹67.36 crore and profit touched at ₹1.55 crore. As of Jun '25, Sandu Pharmaceuticals’s market capitalisation stood at ₹46.99 crores. Shareholding as of Jun '25 shows promoters holding 42.9%, with FIIs at 57.1%, DIIs at %, and public at %.
As of 19 Aug, 2025, Sandu Pharmaceuticals share price is ₹48.6. The stock opened at ₹50.4 and had closed at ₹48.8 the previous day. During today’s trading session, Sandu Pharmaceuticals share price moved between ₹48.05 and ₹50.39, with an average price for the day of ₹49.22. Over the last 52 weeks, the stock has recorded a low of ₹43.75 and a high of ₹69.50. In terms of performance, Sandu Pharmaceuticals share price has declined by 9% over the past six months and has declined by 22.95% over the last year.
Sandu Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹58,05,208 (-10.69%)
Daily SIP of ₹25,000 would have become ₹58,05,208 in 1 year with a gain of ₹-6,94,791 (-10.69%)
Sandu Pharmaceuticals Fundamental
Market Cap (in crs)
46.99
Face Value
10
Turnover (in lacs)
0.26
Key Metrics
Qtr Change %
30.01% Fall from 52W High
-9.4
Dividend yield 1yr %
High in industry
1.6
Sandu Pharmaceuticals Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Sandu Pharmaceuticals Quarterly Revenue
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
14.07 Cr | 18.37 Cr | 17.7 Cr | 17.05 Cr | 15.6 Cr |
Sandu Pharmaceuticals Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
67.36 Cr | 67.7 Cr | 65.68 Cr |
Sandu Pharmaceuticals Quarterly Net Profit/Loss
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
0.33 Cr | 0.56 Cr | 0.5 Cr | 0.17 Cr | 0.59 Cr |
Sandu Pharmaceuticals Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|
1.55 Cr | 1.46 Cr | 1.52 Cr |
Sandu Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
49.10
Current Price
5Day EMA
48.60
10Day EMA
48.60
12Day EMA
48.60
20Day EMA
48.80
26Day EMA
48.90
50Day EMA
49.60
100Day EMA
50.70
200Day EMA
52.80
5Day SMA
48.50
10Day SMA
48.50
20Day SMA
48.50
30Day SMA
49.00
50Day SMA
49.70
100Day SMA
50.60
150Day SMA
51.20
200Day SMA
52.60
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 340 Rs | 532 Rs |
Week Rs | 3452 Rs | 3747 Rs |
Month Rs | 2149 Rs | 2645 Rs |
Resistance & Support
49.03
Pivot
Resistance
First Resistance
50.00
Second Resistance
51.37
Third Resistance
52.34
Support
First Support
47.66
Second support
46.69
Third Support
45.32
Relative Strength Index
48.20
Money Flow Index
76.23
MACD
-0.35
MACD Signal
-0.46
Average True Range
2.62
Average Directional Index
19.72
Rate of Change (21)
-2.72
Rate of Change (125)
-6.01
Sandu Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
39.86 | 48.77 | 37.23 | 61 | 39.57 | -1.93% | -10.09% | -9.74% | -20.67% | -13.19% | 0.00% | 100.28 | 102.86 | 0.72 | |
19.75 | 46.73 | 8.71 | 22.77 | 19.80 | -5.69% | -5.29% | 86.65% | 126.29% | 338.98% | 0.00% | 0.00 | 40.62 | 1.90 | |
49.98 | 49.98 | 26.1 | 67 | 51.00 | -6.82% | -17.81% | 45.67% | 53.50% | 89.68% | 0.00% | 124.95 | 40.62 | 1.47 | |
9.14 | 45.19 | 8.42 | 33.49 | 9.26 | -11.48% | -21.02% | -59.39% | -64.28% | -74.41% | 0.00% | 12.84 | 40.62 | 0.54 | |
59.00 | 44.52 | 46.15 | 85.5 | 55.00 | 7.27% | 1.81% | -4.84% | -19.18% | -41.24% | 0.00% | 51.75 | 40.62 | 1.49 | |
21.08 | 50.47 | 6.4 | 26.31 | 20.08 | -0.38% | -13.30% | 77.88% | 191.53% | 0.00% | 0.00% | 51.20 | 40.62 | 1.31 |
Sandu Pharmaceuticals Latest News
14 AUG 2025 | Thursday
Sandu Pharmaceuticals Ltd - 524703 - Announcement Under Regulation 30-Update-Intimation Of The Conclusion Of Proceeding In Respect Of The Show Cause Notice Received Received From Government Of Maharashtra Department Of Goods And Service Tax As Per Regulation 30 Of The SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015
Sandu Pharmaceuticals Share Price FAQs
How to buy Sandu Pharmaceuticals shares?
You can easily buy Sandu Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Sandu Pharmaceuticals ?
The 52-week high and low of Sandu Pharmaceuticals share price is ₹69.5 and ₹43.75 as of 19/8/2025.
Please be aware that Sandu Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account